Xiang Zheng is an assistant professor of finance at the University of Connecticut. His research interests include fintech, corporate finance, and entrepreneurial finance.
In new research, Xuelin Li, Sijie Wang, Jiajie Xu, and Xiang Zheng find that the involvement of specialized venture capital firms influences a biotech startup’s drug portfolio by focusing research and development on fewer products.